Investor Iaf, Llc
13D/G Filings

This page shows a list of all the recent 13D/G filings made by Iaf, Llc . Schedule 13D is commonly referred to as a “beneficial ownership report.” The term "beneficial owner" is defined under SEC rules. It includes any person who directly or indirectly shares voting power or investment power (the power to sell the security).

When a person or group of persons acquires beneficial ownership of more than 5% of a voting class of a company’s equity securities, they are required to file a Schedule 13D within ten days after the purchase. Click the link icon to see the full transaction history.

Add This Fund
to your dashboard

Date Form Target Prev
Shares		 Current
Shares		 Change
(Percent)		 Ownership
(Percent)		 Change
(Percent)
2025-08-18 13G/A ERNA / Ernexa Therapeutics Inc. 3,255,421 315,779
2025-05-14 13G/A ERNA / Ernexa Therapeutics Inc. 2,679,214 3,255,421
2025-02-12 13G/A ERNA / Ernexa Therapeutics Inc. 576,964 2,679,214
2023-12-20 13G ERNA / Ernexa Therapeutics Inc. 576,964
2023-09-06 13G/A CMRA / Comera Life Sciences Holdings, Inc. 2,736,015 3,133,914
2023-08-10 13G CMRA / Comera Life Sciences Holdings, Inc. 2,736,015